Prediction of immunotherapy response using live tumor fragments from routine clinical biopsies

This publication has 37 references indexed in Scilit:

• Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo
  European Journal of Cancer, 2024
• Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities
  Annals of Oncology, 2024
• Heterogeneous PD-L1 expression in metastases impacts immunotherapy response
  EBioMedicine, 2023
• Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer
  EBioMedicine, 2023
• Immune checkpoint therapy—current perspectives and future directions
  Cell, 2023
• Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
  Clinical Lung Cancer, 2021
• Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
  Cancer Cell, 2021
• Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade
  JAMA Oncology, 2019
• Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
  Cell, 2016
• New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
  European Journal of Cancer, 2009